Liver Directed Gene Therapy: A Long Road to Clinical ApplicationsFERRY, Nicolas.Current gene therapy. 2009, Vol 9, Num 2, issn 1566-5232, 90 p.Serial Issue

Advances in Lentiviral VectorsWIZNEROWICZ, Maciej.Current gene therapy. 2008, Vol 8, Num 6, issn 1566-5232, 84 p.Serial Issue

Gene therapy and the immune systemHERZOG, Roland W.Current gene therapy. 2007, Vol 7, Num 5, issn 1566-5232, 116 p.Serial Issue

Vector traffickingMEDINA-KAUWE, Lali.Gene therapy (Basingstoke). 2005, Vol 12, Num 11, issn 0969-7128, 86 p.Serial Issue

Gene Transfer by Electric FieldsROLS, Marie-Pierre.Current gene therapy. 2010, Vol 10, Num 4, issn 1566-5232, 64 p.Serial Issue

GMP Production of Gene and Cell Therapy TherapeuticsCARRONDO, Manuel; CRUZ, Pedro.Current gene therapy. 2010, Vol 10, Num 6, issn 1566-5232, 104 p.Serial Issue

Special Issue on Gene Therapy for Chronic PainGLORIOSO, Joseph C; FINK, David J.Gene therapy (Basingstoke). 2009, Vol 16, Num 4, issn 0969-7128, 128 p.Serial Issue

Combined Meeting 2009Human gene therapy. 2009, Vol 20, Num 11, pp 1352-1558, issn 1043-0342, 207 p.Conference Paper

BSGT (British Society for Gene Therapy) Annual ConferenceHuman gene therapy. 2008, Vol 19, Num 4, pp 397-401, issn 1043-0342, 4 p.Conference Paper

Intelligent designsGOSSEN, M.Gene therapy (Basingstoke). 2006, Vol 13, Num 17, pp 1251-1252, issn 0969-7128, 2 p.Article

Herpes Simplex Virus Type 1-Based Amplicons VectorsEPSTEIN, Alberto L.Current gene therapy. 2006, Vol 6, Num 3, issn 1566-5232, 147 p.Serial Issue

Recombinant adeno-associated virus: current achievements and limitationsMOULLIER, Philippe.Current gene therapy. 2005, Vol 5, Num 3, issn 1566-5232, 105 p.Serial Issue

Gene Therapy for OrthopaedicsEVANS, Christopher H.Gene therapy (Basingstoke). 2004, Vol 11, Num 4, issn 0969-7128, 85 p.Serial Issue

Cardiovascular Gene TherapyHAJJAR, Roger J.Gene therapy (Basingstoke). 2012, Vol 19, Num 6, issn 0969-7128, 120 p.Serial Issue

The British Society for Gene Therapy (BSGT). Annual ConferenceHuman gene therapy. 2010, Vol 21, Num 4, pp 487-525, issn 1043-0342, 39 p.Conference Paper

Pois(s)on: It's a question of dose..FEHSE, B; KUSTIKOVA, O. S; BUBENHEIM, M et al.Gene therapy (Basingstoke). 2004, Vol 11, Num 11, pp 879-881, issn 0969-7128, 3 p.Article

La thérapie géniqueAnnales de l'Institut Pasteur. Actualités. 1999, Vol 10, Num 3-4, issn 0924-4204, 70 p.Serial Issue

Bacterial Vectors for Gene & Cell TherapyTANGNEY, Mark; GAHAN, Cormac G. M.Current gene therapy. 2010, Vol 10, Num 1, issn 1566-5232, 77 p.Serial Issue

Baculovirus: A Promising Vector for Gene Therapy?HU, Yu-Chen.Current gene therapy. 2010, Vol 10, Num 3, issn 1566-5232, 89 p.Serial Issue

Convergence of Opposite Sciences for the Future Development of Non Viral Gene TherapyPITARD, Bruno.Current gene therapy. 2008, Vol 8, Num 5, issn 1566-5232, 112 p.Serial Issue

BSGT (British Society for Gene Therapy) Annual Conference 2008Human gene therapy. 2008, Vol 19, Num 4, pp 402-422, issn 1043-0342, 20 p.Conference Paper

Prospects of RNAi Therapy for CancerDAVIDSON, B.Gene therapy (Basingstoke). 2006, Vol 13, Num 6, issn 0969-7128, 121 p.Serial Issue

Therapeutic Approaches to Muscular DystrophiesGOYENVALLE, Aurélie.Current gene therapy. 2012, Vol 12, Num 3, issn 1566-5232, 124 p.Serial Issue

Gene Therapy Continues to Make Progress: Clinical and Regulatory PerspectivesCASTRO, Maria G; LOWENSTEIN, Pedro R.Current gene therapy. 2009, Vol 9, Num 5, issn 1566-5232, 109 p.Serial Issue

BSGT Annual ConferenceHuman gene therapy. 2009, Vol 20, Num 4, pp 390-422, issn 1043-0342, 32 p.Conference Paper